Article Information
History
- February 22, 2021.
Article Versions
- You are currently viewing Version 1 of this article (February 22, 2021 - 18:09).
- Version 2 (August 9, 2021 - 22:20).
- Version 3 (August 11, 2021 - 21:30).
- View Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Swarnima Singh1,2,
- Nigel Lee3,
- Igor Bado1,
- Clark Hamor1,
- Licheng Zhang6,
- Sergio Aguirre1,
- Jingyuan Hu3,
- Yichao Shen1,
- Yitian Xu6,
- Yang Gao1,
- Diego Pedroza1,
- Na Zhao1,
- Shu-Hsia Chen6,
- Ying-Wooi Wan3,
- Zhandong Liu3,
- Jeffrey T. Chang4,
- Daniel Hollern7,
- Charles M. Perou5,
- Xiang H.F. Zhang1,2,* and
- Jeffrey M. Rosen1,2,*
- 1Department of Molecular and Cellular Biology and Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine
- 2Translational Biology and Molecular Medicine, Baylor College of Medicine
- 3Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, Houston, United States
- 4Department of Integrative Biology and Pharmacology, The University of Texas Health Science Center at Houston
- 5Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA
- 6Immunominotoring Core, Center for Immunotherapy Research, Houston Methodist Research Institute (HMRI), 6670 Bertner Avenue, R9-330.11, Houston, Texas 77030
- 7Salk Institute for Biological Studies, Salk Cancer Center, NOMIS Center for Immunobiology and Microbial Pathogenesis, 10010 N Torrey Pines Rd • La Jolla, CA 92037
- ↵*Co-corresponding authors; email: jrosen{at}bcm.edu